Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD.

Bilson, Josh; Scorletti, Eleonora; Bindels, Laure B; Afolabi, Paul R; Targher, Giovanni; Calder, Philip C; Sethi, Jaswinder K; Byrne, Christopher D

Bilson, Josh; Scorletti, Eleonora; Bindels, Laure B; Afolabi, Paul R; Targher, Giovanni; Calder, Philip C; Sethi, Jaswinder K; Byrne, Christopher D.

Afiliación

Bilson J; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
Scorletti E; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service Foundation Trust, Southampton, UK.
Bindels LB; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
Afolabi PR; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service Foundation Trust, Southampton, UK.
Targher G; Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Calder PC; Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.
Sethi JK; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
Byrne CD; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service Foundation Trust, Southampton, UK.

Nutr Diabetes ; 11(1): 32, 2021 10 18.

Article en En | MEDLINE | ID: mdl-34663793

Asunto(s)

Diabetes Mellitus Tipo 2/sangre; Factor 15 de Diferenciación de Crecimiento/sangre; Cirrosis Hepática/sangre; Enfermedad del Hígado Graso no Alcohólico/sangre; Adulto; Anciano; Diabetes Mellitus Tipo 2/epidemiología; Diagnóstico por Imagen de Elasticidad/métodos; Femenino; Hemoglobina Glucada/análisis; Humanos; Inmunoensayo/métodos; Cirrosis Hepática/epidemiología; Cirrosis Hepática/metabolismo; Modelos Logísticos; Masculino; Persona de Mediana Edad; Enfermedad del Hígado Graso no Alcohólico/epidemiología; Curva ROC; Ensayos Clínicos Controlados Aleatorios como Asunto; Factores de Riesgo; Adulto Joven

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Factor 15 de Diferenciación de Crecimiento / Enfermedad del Hígado Graso no Alcohólico / Cirrosis Hepática Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nutr Diabetes Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google